Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
6.13
+0.05 (0.82%)
Nov 21, 2024, 4:00 PM EST - Market closed
Larimar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 391 | 200 | 179 | 191 | 329 | - | |
| Market Cap Growth | 144.48% | 11.79% | -6.49% | -41.88% | - | - | |
| Enterprise Value | 190 | 110 | 60 | 119 | 233 | - | |
| Last Close Price | 6.08 | 4.55 | 4.13 | 10.79 | 21.41 | - | |
| PB Ratio | 1.96 | 2.44 | 1.61 | 2.97 | 3.67 | - | |
| P/TBV Ratio | 2.11 | 2.44 | 1.61 | 2.97 | 3.67 | - | |
| Debt / Equity Ratio | 0.03 | 0.07 | 0.05 | 0.09 | 0.07 | -0.14 | |
| Quick Ratio | 12.57 | 9.13 | 11.06 | 7.95 | 10.31 | 0.20 | |
| Current Ratio | 13.10 | 9.49 | 11.28 | 8.16 | 10.89 | 0.81 | |
| Return on Equity (ROE) | -44.50% | -38.36% | -40.33% | -65.72% | -95.47% | -2083.96% | |
| Return on Assets (ROA) | -28.55% | -23.48% | -22.26% | -34.40% | -48.69% | -280.42% | |
| Return on Capital (ROIC) | -30.54% | -25.64% | -24.45% | -37.86% | -55.96% | -1252.37% | |
| Earnings Yield | -16.39% | -18.50% | -19.78% | -26.50% | -12.92% | - | |
| FCF Yield | -14.87% | -16.83% | -15.48% | -22.21% | -12.85% | - | |
| Buyback Yield / Dilution | -28.05% | -70.41% | -50.09% | -44.44% | -95.09% | - | |
| Total Shareholder Return | -28.05% | -70.41% | -50.09% | -44.44% | -95.09% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.